TrialThe lancet. HIV2023

Rapid access to antiretroviral therapy, receipt of naltrexone, and strengths-based case management versus standard of care for HIV viral load suppression in people with HIV who inject drugs in Russia (LINC-II): an open-label, randomised controlled trial.

Jeffrey H Samet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.